R. Wood

发表

Interventions for preventing osteoradionecrosis of the jaws in adults receiving head and neck radiotherapy.

Howard C. Tenenbaum, P. Shah, A. Azarpazhooh, 2015, The Cochrane database of systematic reviews.

Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity‐modulated radiotherapy

B. O'Sullivan, A. Hope, John J. Kim, 2017, Cancer.

Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial.

P. Mitchell, N. Bressler, M. Gallagher, 2013, JAMA ophthalmology.

Patient-reported Quality of Life and Treatment Satisfaction in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer.

D. Mitra, S. Iyer, J. de Courcy, 2017, Clinical therapeutics.

Symptoms Reported by Head and Neck Cancer Patients during Radiotherapy and Association with Mucosal Ulceration Site and Size: An Observational Study

Howard C. Tenenbaum, A. Hope, A. Jokstad, 2015, PloS one.

Assessment of Cancer Therapy-Induced Oral Mucositis Using a Patient-Reported Oral Mucositis Experience Questionnaire

Howard C. Tenenbaum, A. Hope, A. Jokstad, 2014, PloS one.

The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: an analysis of 573 patients by the Medical Research Council Working Party on Gynaecological Cancer

D. Cruickshank, C. Redman, D. Parker, 1992, International Journal of Gynecologic Cancer.

Delays in diagnosis of head and neck cancers.

Howard C. Tenenbaum, R. Wood, Thomas Yu, 2008, Journal.

RADIATION-INDUCED MUCOSITIS IN PATIENTS WITH HEAD AND NECK CANCER: SHOULD THE SIGNS OR THE SYMPTOMS BE MEASURED?

Howard C. Tenenbaum, A. Hope, A. Jokstad, 2015, Journal.

The humanistic burden associated with caring for patients with advanced non-small cell lung cancer (NSCLC) in three European countries—a real-world survey of caregivers

G. Taylor‐Stokes, M. Lees, R. Wood, 2018, Supportive Care in Cancer.

The effect of pamidronate delivery in bisphosphonate-naïve patients on neutrophil chemotaxis and oxidative burst

Howard C. Tenenbaum, J. W. Chadwick, M. Glogauer, 2020, Scientific Reports.

Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage

R. Wood, R. Wood, G. Taylor-Stokes, 2019, BMC Cancer.

The humanistic burden of advanced non-small cell lung cancer (NSCLC) in Europe: a real-world survey linking patient clinical factors to patient and caregiver burden

R. Wood, C. Chaib, G. Taylor-Stokes, 2019, Quality of Life Research.

Patient Reported Health Utility in HR+/HER2- Advanced/Metastatic Breast Cancer

D. Mitra, S. Iyer, R. Wood, 2016 .

Patient-reported pain severity, pain interference and health status in HR+/HER2− advanced/metastatic breast cancer

D. Mitra, S. Iyer, J. de Courcy, 2017, ESMO Open.

A primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidity

T. Miller, D. DeWalt, M. Pignone, 2005, BMC health services research.

Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma--response rate and pitfalls. MRC Subgroup in Advanced Bladder Cancer (on behalf of the MRC Urological Working Party).

S. Fosså, M. Parmar, S. Kaye, 1992, British journal of urology.